Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 10, 2023. (Total: 223917Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Myeloproliferative Disorders and BCR[original query]
The Janus Kinase 2 (JAK2) V617F mutation in hematological malignancies in México.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 0 58 (5): 458-61.
Ruiz-Argüelles Guillermo J, Garcés-Eisele Javier, Reyes-Núñez Virginia, Ruiz-Delgado Guillermo J, Navarro-Vázquez Morelis, González-Carrillo Martha
MPL W515L mutation in Chinese patients with myeloproliferative diseases.
Leukemia & lymphoma 2008 May 49 (5): 955-8.
Xu Wei, Li Jian-Yong, Xia Jun, Zhang Su-Jiang, Fan Lei, Qiao Ch
[Tyrosine kinase JAK2V617F mutation in human myeloproliferative disorders].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2009 Jun 17 (3): 541-4.
Xu Yuan-Yuan, Li Hui-Min, Li Xiao-Jin, Yang Ling, Hu Deng-Mi
GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
Leukemia research 2009 Mar .
Zhang SJ, Shi JY, Li JY
JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.
Pathologie-biologie 2011 Aug 59 (4): e89-92.
Benmoussa A, Dehbi H, Fehri S, Quessar A, Nadifi
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Aug 19 (4): 916-20.
Zhu Jun-Fang, Liu Yuan, Liu Pei, Jia Ming-Feng, Cheng Juan, Zhao
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.
Haematologica 2012 Oct 97 (10): 1582-5.
Schnittger Susanne, Bacher Ulrike, Eder Christiane, Dicker Frank, Alpermann Tamara, Grossmann Vera, Kohlmann Alexander, Kern Wolfgang, Haferlach Claudia, Haferlach Torst
Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan.
Pakistan journal of medical sciences 2014 Jan 30 (1): 185-8.
Tabassum Najia, Saboor Mohammed, Ghani Rubina, Moinuddin Moinudd
TOP